Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qiagen (QGEN) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Qiagen (QGEN) over the last 17 years, with Q4 2025 value amounting to $2.0 billion.

  • Qiagen's Total Non-Current Liabilities fell 8143.33% to $2.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.0 billion, marking a year-over-year decrease of 8143.33%. This contributed to the annual value of $2.0 billion for FY2025, which is 8143.33% down from last year.
  • Qiagen's Total Non-Current Liabilities amounted to $2.0 billion in Q4 2025, which was down 8143.33% from $1.9 billion recorded in Q3 2025.
  • In the past 5 years, Qiagen's Total Non-Current Liabilities ranged from a high of $10.8 billion in Q4 2024 and a low of $1.1 billion during Q2 2024
  • For the 5-year period, Qiagen's Total Non-Current Liabilities averaged around $2.2 billion, with its median value being $1.8 billion (2023).
  • Per our database at Business Quant, Qiagen's Total Non-Current Liabilities skyrocketed by 77958.89% in 2024 and then tumbled by 8143.33% in 2025.
  • Over the past 5 years, Qiagen's Total Non-Current Liabilities (Quarter) stood at $1.5 billion in 2021, then grew by 20.46% to $1.8 billion in 2022, then tumbled by 33.49% to $1.2 billion in 2023, then skyrocketed by 779.59% to $10.8 billion in 2024, then plummeted by 81.43% to $2.0 billion in 2025.
  • Its Total Non-Current Liabilities stands at $2.0 billion for Q4 2025, versus $1.9 billion for Q3 2025 and $1.2 billion for Q2 2025.